Patent US4606920A successfully refreshed from Google Patents.
US4606920A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Pharmaceutical composition suitable for treatment of inflammatory changes of the bronchial mucosa
Assignee: Individual
•
Filing: 1984-03-02
•
Granted: 1986-08-19
•
Expires: 2004-03-02
Abstract
Abstract A pharmaceutical composition is being described that contains pharmacologically acceptable magnesium compounds, etofylline, vitamin A and vitamin C. It is especially suitable for treatment of inflammatory changes of the bronchial mucosa.
Inventors
- 👤 Hans-Peter Walter
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 18:25
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/495; A61K31/505; A61K31/519; A61K31/52; A61K33/00; A61K33/06; A61K33/42; A61P; A61P11/00; A61P11/08
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
43 words
A pharmaceutical composition in unit dosage form for the treatment of inflammatory changes and diseases of the bronchial mucosa comprising of between 100 and 200 mg of etofylline; vitamin A up to about 50,000 I.U. and between 50 and 70 mg of magnesium.
Claim 2
Dependent Claim
43 words
A pharmaceutical composition in unit dosage form for the treatment of inflammatory changes and diseases of the bronchial mucosa comprising of between 100 and 200 mg of etofylline; vitamin A up to about 50,000 I.U. and between 50 and 70 mg of magnesium.
Claim 3
Independent Claim
47 words
A method for treatment of inflammatory changes and diseases of the bronchial mucosa in humans comprising the administration to a human in need thereof of a daily dosage of about 200 mg of etofylline, up to 50,000 I.U. of vitamin A and about 70 mg of magnesium.
Claim 4
Independent Claim
47 words
A method for treatment of inflammatory changes and diseases of the bronchial mucosa in humans comprising the administration to a human in need thereof of a daily dosage of about 200 mg of etofylline, up to 50,000 I.U. of vitamin A and about 70 mg of magnesium.
References Cited (Backward Citations)
US4246264A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1989-08-18 | 1990-02-17 | 1990-08-19 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1993-08-18 | 1994-02-17 | 1994-08-19 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1997-08-18 | 1998-02-17 | 1998-08-19 | $7700.00 | Window Closed / Lapsed |